Schedule 13G ownership disclosure
Galena Biopharma, Inc.
Security class unavailable · CUSIP: 363256108
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 541,463
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-17-000051
- Form type
- SC 13G
- Filer
- SELLAS Life Sciences Group, Inc.
- CIK
- CIK 1390478
- Filed
- Jan 11, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership